NEW YORK (GenomeWeb News) – A National Cancer Institute review panel has recommended that the Wistar Institute Cancer Center receive $14.9 million in renewal funding to support resources and infrastructure for a range of molecular cancer research activities.

The five-year renewal will fund Wistar's shared resources, which include molecular screening and imaging tools and genomics research technologies, Philadelphia-based Wistar said last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.